News

August 31, 2017 12:00 pm
 Novartis’ CAR-T gene therapy, the first approved by FDA, to cost $475,000  - Novartis AG’s CAR-T cell therapy was approved by the Food and Drug Administration on August 30, 2017, making it the first gene therapy to be available in the U.S.  ...
August 18, 2017 10:45 am

Pages